Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/12/2010WO2010089616A1 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
08/12/2010WO2010089580A1 Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4
08/12/2010WO2010089559A1 Cancer diagnosis and treatment
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089509A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089508A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089507A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089506A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089475A1 Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
08/12/2010WO2010089391A1 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
08/12/2010WO2010089361A2 Process for the preparation of a pharmaceutical composition comprising ezetimibe
08/12/2010WO2010089355A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
08/12/2010WO2010089330A1 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
08/12/2010WO2010089327A2 Indole derivatives as anticancer agents
08/12/2010WO2010089303A1 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
08/12/2010WO2010089297A1 Isoxazole-5-carboxamide derivatives
08/12/2010WO2010089292A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010089119A1 Heterocyclic derivatives as m-glu5 antagonists
08/12/2010WO2010089107A1 Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors
08/12/2010WO2010089105A2 Moisture-activated granulation process
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010089078A1 Buccal application system comprising 17α-estradiol
08/12/2010WO2010088924A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/12/2010WO2010088842A1 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof
08/12/2010WO2010088827A1 Novel uses of huperzine a and ophthalmic preparations thereof
08/12/2010WO2010088803A1 New porcine reproductive and respiratory syndrome virus receptor, and blockers thereof
08/12/2010WO2010061219A3 Polymorphs
08/12/2010WO2010061142A3 Composition containing an angiotensin ii at2 receptor antagonist, intended for slowing cancer cell tumor initiation in a high-risk mammal
08/12/2010WO2010060529A8 Microparticles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone
08/12/2010WO2010059531A3 Alpha-keto peracids and methods for producing and using the same
08/12/2010WO2010054126A3 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/12/2010WO2010054042A3 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity
08/12/2010WO2010054015A3 Methods of reducing the risk of cardiovascular disease in postmenopausal women
08/12/2010WO2010050802A3 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
08/12/2010WO2010046865A3 Ophthalmic administration of a composition including brimonidine as a mist
08/12/2010WO2010045529A3 Combination therapies for the treatment of obesity
08/12/2010WO2010045199A3 Method of modulating ship activity
08/12/2010WO2010042868A3 Methods for treating obesity
08/12/2010WO2010042758A3 Oxazole-pyridazine-oxazole alpha-helix mimetic
08/12/2010WO2010042685A3 Inhibitors of the atb(0,+) transporter and uses thereof
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010WO2010040345A3 Ecdysone derivatives and the use thereof
08/12/2010WO2010040312A8 Hollow mesoporous silica sphere coated with gold and preparation method thereof and use in cancer therapy
08/12/2010WO2010039977A3 Heteroaryl antagonists of prostaglandin d2 receptors
08/12/2010WO2010039538A3 Flavivirus inhibitors and methods for their use
08/12/2010WO2010036640A3 Compounds for the treatment of inflammatory disorders
08/12/2010WO2010032976A9 Composition for prevention or treatment of heart failure
08/12/2010WO2010032154A4 Gangliosides from the avian nervous system and their uses for the diagnosis and the treatment of proventricular dilatation disease
08/12/2010WO2010032043A3 Antimicrobial and/or anti-acne formulations containinga dialkyl sulphosuccinate or derivative thereof
08/12/2010WO2010030811A3 CARBACEPHEM β-LACTAM ANTIBIOTICS
08/12/2010WO2010030808A3 Novel antibiotics against resistant bacteria
08/12/2010WO2010015400A3 Injectable taxane pharmaceutical composition
08/12/2010WO2010011546A3 Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity
08/12/2010WO2010006342A3 Compositions and methods for inhibiting expression of gsk-3 genes
08/12/2010WO2010001413A3 Sustained release pharmaceutical compositions comprising quetiapine
08/12/2010WO2009152189A8 Low dose topiramate/phentermine compostion and methods of use thereof
08/12/2010WO2009137085A8 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
08/12/2010WO2009117410A8 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques
08/12/2010WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
08/12/2010WO2009108360A3 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
08/12/2010WO2009097287A8 Compounds and compositions as kinase inhibitors
08/12/2010WO2009082437A9 Selective androgen receptor modulators (sarms) and uses thereof
08/12/2010WO2009065287A8 Novel mangiferin calcium salts, the method for its preparation and its use
08/12/2010WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
08/12/2010US20100204673 Obesity controlling method
08/12/2010US20100204481 Compounds capable of activating cholinergic receptors
08/12/2010US20100204469 Conjugated psychotropic drugs and uses thereof
08/12/2010US20100204340 Orally bioavailable stilbenoids- compositions and therapeutic applications thereof
08/12/2010US20100204339 Orally Bioavailable Stilbenoids- Compositions and Therapeutic Applications Thereof
08/12/2010US20100204338 Anti-angiogenic agents and methods of use
08/12/2010US20100204337 Antibacterial s-heterosubstituted disulfides
08/12/2010US20100204336 Formoterol Tartrate Process and Polymorph
08/12/2010US20100204335 Kit and composition for eyelash growth
08/12/2010US20100204334 Intranasal Delivery of Modafinil
08/12/2010US20100204333 Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme Inhibitor
08/12/2010US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel
08/12/2010US20100204331 Prostaglandin deriative-containing aqueous liquid preparation
08/12/2010US20100204330 Diclofenac Formulations and Methods of Use
08/12/2010US20100204329 Method of using and establishing an absorption rate level and a neuron firing level
08/12/2010US20100204328 Solution and Method to Reduce, Treat and/or Prevent Oxidative Stress and Cell Activation
08/12/2010US20100204327 Methods for making retinoids and uses thereof
08/12/2010US20100204326 Novel agents for treatment of ailments and dysfunctions
08/12/2010US20100204324 Optically Active N-(Alpha-Mercaptopropionyl)Glycine
08/12/2010US20100204322 Method of treating autoimmune diseases
08/12/2010US20100204321 Antitussive and Bronchodilator uses for enaminone ester
08/12/2010US20100204320 Pharmaceuticals for xerosis
08/12/2010US20100204319 Treatment for benign prostatic hyperplasia
08/12/2010US20100204318 Treatment of virally induced lesions
08/12/2010US20100204317 Methods of treating dermatological disorders or conditions
08/12/2010US20100204316 Pseudopolymorphic forms of a hiv protease inhibitor
08/12/2010US20100204314 Drug for treatment of influenza
08/12/2010US20100204313 Modulation of nerve pain activity by resiniferatoxin and uses thereof
08/12/2010US20100204312 Methods and compositions for treating cancer
08/12/2010US20100204311 Normal-tension glaucoma model and method for evaluation of test substances by using same
08/12/2010US20100204310 New modalities for treatment of drug-resistant tuberculosis and other diseases
08/12/2010US20100204309 Oligonucleotide compositions for the treatment of alzheimer's disease
08/12/2010US20100204308 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
08/12/2010US20100204306 Method of Treating Neurodegenerative Disease
08/12/2010US20100204305 Small interfering rna molecules against ribonucleotide reductase and uses thereof
1 ... 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 ... 7860